Advertisement

Ads Placeholder
Loading...

CSL Limited

CMXHF•PNK
Healthcare
Biotechnology
$98.24
$9.94(11.26%)
U.S. Market opens in 5h 1m

CSL Limited (CMXHF) Stock Overview

Explore CSL Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap47.7B
P/E Ratio33.00
EPS (TTM)$6.17
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$94.37
3 Months$96.61
1 Year Target$105.96

CMXHF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CSL Limited (CMXHF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.63, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $105.96.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 33.00 and a market capitalization of 47.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
11.26%
5-Day Change
3.94%
1-Month Change
-0.54%
3-Month Change
-18.11%
6-Month Change
-24.43%
Year-to-Date (YTD) Change
-17.83%
1-Year Change
-33.58%
3-Year Change
-50.73%
5-Year Change
-50.93%
All-Time (Max) Change
3565.67%

Contact Information

https://www.csl.com.au
61 3 9389 1911
45 Poplar Road, Melbourne, VIC, 3052

Company Facts

326,980 Employees
IPO DateNov 18, 2005
CountryAU
Actively Trading

Frequently Asked Questions